Tadesse 2016
| Study characteristics | |||
| Patient sampling | Cross‐sectional design, consecutive enrolment of participants, prospective data collection | ||
| Patient characteristics and setting | Presenting signs and symptoms: clinical suspicion of TB, smear‐negative Age: 18 years and older, median 38 years (IQR 23 to 55) Sex, female: 38% HIV infection: 0% History of TB: not reported Sample size: 185 Clinical setting: not reported Laboratory level: central Country: Ethiopia World Bank Income Classification: low income High TB burden country: yes High MDR‐TB burden country: yes High TB/HIV burden country: yes Prevalence of TB cases in the study: 10.3% |
||
| Index tests | Index: Xpert MTB/RIF | ||
| Target condition and reference standard(s) | Target condition: pulmonary TB Reference standard for pulmonary TB: LJ and MGIT 960 Target condition: rifampicin resistance Reference standard for rifampicin resistance: LJ and MGIT 960 |
||
| Flow and timing | |||
| Comparative | |||
| Notes | "One hundred twenty‐four patients were excluded from the study (56 were HIV‐positive/unknown, 30 were smear positive, 19 provided a sample with inadequate volume, 13 did not provide three sputa, and six had missing acid‐fast bacilli‐smear results)." | ||
| Methodological quality | |||
| Item | Authors' judgement | Risk of bias | Applicability concerns |
| DOMAIN 1: Patient Selection | |||
| Was a consecutive or random sample of patients enrolled? | Yes | ||
| Was a case‐control design avoided? | Yes | ||
| Did the study avoid inappropriate exclusions? | No | ||
| High | Unclear | ||
| DOMAIN 2: Index Test Xpert MTB/RIF | |||
| Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
| If a threshold was used, was it pre‐specified? | Yes | ||
| Low | Low | ||
| DOMAIN 3: Reference Standard | |||
| Is the reference standards likely to correctly classify the target condition? | Yes | ||
| Were the reference standard results for TB detection interpreted without knowledge of the results of the index test? | Yes | ||
| Were the reference standard results for rifampicin resistance detection interpreted without knowledge of the results of the index test? | Yes | ||
| Low | Low | ||
| DOMAIN 4: Flow and Timing | |||
| Was there an appropriate interval between index test and reference standard? | Yes | ||
| Did all patients receive the same reference standard? | Yes | ||
| Were all patients included in the analysis? | Yes | ||
| Low | |||